Pembatalan Sepihak Akta Kuasa Khusus Dari Pemberi Kuasa Kepada Penerima Kuasa Terkait Dengan Kredit Modal Kerja Konstruksi
Lex Librum : Jurnal Ilmu Hukum · 2018
DOI: 10.46839/lljih.v10i2.934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lex Librum : Jurnal Ilmu Hukum, 2018. Verfasst von M. Dafi Siddiq Aldisahr und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Regarding the legal consequences of unilaterally canceling a power of attorney in the case of working capital loans for construction, special requirements must be met by the bank when lending working capital for construction projects so that it is not canceled and sued unilaterally. This can be done with a power of attorney if it can be proven that the person giving the power of attorney is not carrying out their duties properly. The legal consequences of unilaterally revoking the special authority law are administrative sanctions and judicial revocation of the special authority law. Special requirements for granting working capital credit are met with two-way verification, especially for parties who provide special authority. This is to avoid further legal problems and the principal has the right to take legal action if his representative does not meet the requirements.
Zitieren
APA
Aldisahr, M. D. S., Yahanan, A., & Samawati, P. (2018). Pembatalan Sepihak Akta Kuasa Khusus Dari Pemberi Kuasa Kepada Penerima Kuasa Terkait Dengan Kredit Modal Kerja Konstruksi. Lex Librum : Jurnal Ilmu Hukum. https://doi.org/10.46839/lljih.v10i2.934
Vancouver
Aldisahr MDS, Yahanan A, Samawati P. Pembatalan Sepihak Akta Kuasa Khusus Dari Pemberi Kuasa Kepada Penerima Kuasa Terkait Dengan Kredit Modal Kerja Konstruksi. Lex Librum : Jurnal Ilmu Hukum. 2018. doi:10.46839/lljih.v10i2.934
BibTeX
@article{Aldisahr2018,
author = {Aldisahr, M. Dafi Siddiq and Yahanan, Annalisa and Samawati, Putu},
title = {Pembatalan Sepihak Akta Kuasa Khusus Dari Pemberi Kuasa Kepada Penerima Kuasa Terkait Dengan Kredit Modal Kerja Konstruksi},
journal = {Lex Librum : Jurnal Ilmu Hukum},
year = {2018},
doi = {10.46839/lljih.v10i2.934}
}
EUVIMED